Steven M Paul Alnylam Pharmaceuticals, Inc. (ALNY) insider trading activity

ALNY Quotes by TradingView

Steven M Paul is Director of ALNYLAM PHARMACEUTICALS, INC.. Currently has a direct ownership of 1,000 shares of ALNY, which is worth approximately $250,980. The most recent transaction as insider was on Apr 01, 2022, when has been sold 15,000 shares (Common Stock) at a price of $172.8 per share, resulting in proceeds of $2,592,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1K
0% 3M change
0% 12M change
Total Value Held $250,980

STEVEN M PAUL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 01 2022
SELL
Open market or private sale
$2,592,000 $172.8 p/Share
15,000 Reduced 93.75%
1,000 Common Stock
Apr 01 2022
BUY
Exercise of conversion of derivative security
$169,950 $11.33 p/Share
15,000 Added 48.39%
16,000 Common Stock
Dec 18 2020
SELL
Open market or private sale
$2,100,000 $140.0 p/Share
15,000 Reduced 93.75%
1,000 Common Stock
Dec 18 2020
BUY
Exercise of conversion of derivative security
$139,500 $9.3 p/Share
15,000 Added 48.39%
16,000 Common Stock

Also insider at

KRTX
Karuna Therapeutics, Inc. Healthcare
VYGR
Voyager Therapeutics, Inc. Healthcare
Director
SAGE
Sage Therapeutics, Inc. Healthcare
SMP

Steven M Paul

Director
Cambridge, MA

Track Institutional and Insider Activities on ALNY

Follow ALNYLAM PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALNY shares.

Notify only if

Insider Trading

Get notified when an Alnylam Pharmaceuticals, Inc. insider buys or sells ALNY shares.

Notify only if

News

Receive news related to ALNYLAM PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ALNY